Cover Image

Editorial: The gut-kidney axis: A potential drug target for treating kidney diseases

Saved in:

Bibliographic Details
Main Authors:	Jianping Chen (Author), Karl W. K. Tsim (Author), Kun Gao (Author), Mahyar Khazaeli (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication
by: José Arimatéa de Oliveira Nery Neto, et al.
Published: (2023)

Editorial: Applications of Herbal Medicine to Control Chronic Kidney Disease
by: Jianping Chen, et al.
Published: (2021)

Editorial: Applications of herbal medicine to control chronic kidney disease: Volume II
by: Jianping Chen, et al.
Published: (2022)

Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut-Kidney Axis
by: Chien-Ning Hsu, et al.
Published: (2021)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
by: Yinghui Huang, et al.
Published: (2022)

The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease
by: Leilei Ma, et al.
Published: (2023)

Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition
by: Meilian Yu, et al.
Published: (2022)

Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis
by: Hua Chen, et al.
Published: (2020)

Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
by: Zuoquan Xie, et al.
Published: (2022)

The gut-kidney connection in advanced chronic kidney disease
by: Reiko Inagi
Published: (2015)

A troubled mind troubles the kidney: a brain-to-kidney axis?
by: Keun You Kim, et al.
Published: (2022)

Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut-kidney axis
by: Hongmei Yu, et al.
Published: (2024)

Kidney-targeted drug delivery systems
by: Peng Zhou, et al.
Published: (2014)

Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
by: Xia-Qing Wu, et al.
Published: (2024)

Research Progress of Drug Delivery Systems Targeting the Kidneys
by: Li-Feng Huang, et al.
Published: (2024)

Gut-immunity-joint axis: a new therapeutic target for gouty arthritis
by: Pei Chen, et al.
Published: (2024)

Effect of psychological stress on the oral-gut microbiota and the potential oral-gut-brain axis
by: Durga Paudel, et al.
Published: (2022)

Role of the Gut Microbiota in Children with Kidney Disease
by: You-Lin Tain, et al.
Published: (2023)

Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease
by: Yuan Gao, et al.
Published: (2024)

Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
by: Sebastian N. Knoppert, et al.
Published: (2019)

Gut Microbiota: Target for Modulation of Gut-Liver-Adipose Tissue Axis in Ethanol-Induced Liver Disease
by: Dhara Patel, et al.
Published: (2022)

The Role of Gut Microbiota-Gut-Brain Axis in Perioperative Neurocognitive Dysfunction
by: Jian Lu, et al.
Published: (2022)

Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation
by: Lin Zheng, et al.
Published: (2023)

A Review of Edible Jujube, the Ziziphus jujuba Fruit: A Heath Food Supplement for Anemia Prevalence
by: Jianping Chen, et al.
Published: (2020)

Gut microbiota modulation in the chronic kidney disease management
by: Łukasz Dobrek
Published: (2022)

MG53: A potential therapeutic target for kidney disease
by: Ben Ke, et al.
Published: (2023)

The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases
by: Wei Tang, et al.
Published: (2022)

Microbiota-gut-brain axis: a new target for toxicity of environmental pollutants
by: Anyu NI, et al.
Published: (2023)

Editorial: Acute Kidney Injury: It's Not Just Acute, and It's Not Just the Kidneys
by: Danielle E. Soranno, et al.
Published: (2021)

Nanocarrier-Based Drug Delivery Systems Targeting Kidney Diseases
by: Laura Zucaro, et al.
Published: (2024)

Editorial: Metalloenzymes: Potential Drug Targets
by: Jamshed Iqbal, et al.
Published: (2021)

Gut-vascular axis and postbiotics: The pharmacological potential of metabolites encourages broader definitions
by: Lorenzo Flori, et al.
Published: (2024)

Unveiling the Potential of Gut Microbiota: Promising Approaches to Treat Drug-Resistant Epilepsy
by: Natalia Domańska, et al.
Published: (2024)

Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases
by: Jinwei Zhang, et al.
Published: (2023)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
by: Bo Zhang, et al.
Published: (2022)

Recent advances of gut microbiota in chronic kidney disease patients
by: Ying-Yong Zhao
Published: (2022)

Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with Traditional Chinese Medicine retention enema in real-world patients with stage 3-5 chronic kidney disease (non-dialysis) based on the theory of the Gut-Kidney axis
by: Yanli Deng, et al.
Published: (2024)

Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function
by: Predrag Sikiric, et al.
Published: (2023)

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
by: Zhenyu Zhu, et al.
Published: (2022)

Stachyose Alleviates Corticosterone-Induced Long-Term Potentiation Impairment via the Gut-Brain Axis
by: Yan Huang, et al.
Published: (2022)